Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Progenitor cell therapy and myocardial infarction: the importance of microvascular function

Nature Clinical Practice Cardiovascular Medicine volume 5, pages 78–79 (2008)Cite this article

boxed-textErbs S et al. (2007) Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial. Circulation 116: 366–374

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bishop AH and Samady H (2004) Fractional flow reserve: critical review of an important physiologic adjunct to angiography. Am Heart J 147: 792–802

    Article  Google Scholar 

  2. Werner N et al. (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999–1007

    Article  CAS  Google Scholar 

  3. Wollert KC and Drexler H (2005) Clinical applications of stem cells for the heart. Circ Res 96: 151–163

    Article  CAS  Google Scholar 

  4. Friedrich EB et al. (2006) CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 98: e20–e25

    Article  CAS  Google Scholar 

  5. Seeger FH et al. (2007) Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 28: 766–772

    Article  Google Scholar 

  6. Young PP et al. (2007) Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog Cardiovasc Dis 49: 421–429

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. C Werner is a third-year resident, M Böhm is Cardiologist-in-Chief and Director, and EB Friedrich is an Attending Cardiologist, at the Clinic for Internal Medicine III of the Saarland University Hospital, Homburg, Germany.,

    Christian Werner, Michael Böhm & Erik B Friedrich

Authors
  1. Christian Werner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Böhm
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Erik B Friedrich
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erik B Friedrich.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Werner, C., Böhm, M. & Friedrich, E. Progenitor cell therapy and myocardial infarction: the importance of microvascular function. Nat Rev Cardiol 5, 78–79 (2008). https://doi.org/10.1038/ncpcardio1058

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio1058

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing